India Gives Emergency Authorization to World’s First DNA-Based COVID-19 Vaccine

India Gives Emergency Authorization to World’s First DNA-Based COVID-19 Vaccine
The three-dose ZyCoV-D vaccine produced by India-based Cadila Healthcare. Zydus Cadila
Updated:

The world’s first plasmid DNA vaccine against COVID-19 has been given emergency authorization by India’s drug regulator for use in those aged 12 and above.

The Drug Controller General of India (DCGI) on Aug. 20 granted emergency use authorization to the vaccine ZyCoV-D, a vaccine produced by India-based drugmaker Zydus Cadila and developed in partnership with India’s Department of Biotechnology.

Related Topics